ZURICH, Switzerland, April 19, 2024 (GLOBE NEWSWIRE) -- Today, Life Science
Cares, a collective effort of the life science industry to reduce the impact of
poverty and inequality in their communities, launched in Switzerland, marking
its first expansion as an independent association into geographies outside of
the United States.
"We are excited to launch Life Science Cares Switzerland (LSCS) today, in time,
to engage with the local community at the upcoming Swiss Biotech Day in Basel,"
said Nadine Zahnd, Managing Director of LSCS. "At the heart of our life sciences
community is the overwhelming sense to act and do good. We are building bridges
between Swiss Life Science Organizations and local charitable organizations for
individuals who may otherwise fail to access the opportunities afforded to so
many of us."
In Switzerland in 2021, 1.24 million people, including many families are
considered at the brink of poverty. Those affected are at risk of losing their
social contacts and often suffer from psychological and physical health
problems. Children in such families face often insurmountable obstacle to reach
their full potential. It is the mission of LSCS to break this cycle and offer a
path to unlock opportunity.
At the Swiss Biotech Day, LSCS will be showcased in the Plenary Session on 22
April 2024 and in a dedicated Panel discussion featuring the Swiss Red Cross,
Cooley LLP, Novartis, the Swiss Biotech Association (SBA) and Molecular Partners
at 4.30 pm at Marriott Hotel in Basel. Information will be available for
everyone who wishes to contribute to our mission at the SBA Booth.
The Board of LSCS will be constituted by Isabel Dalli, Novartis; Sarah
MacDonald, CEO LSC, Inc.; Dorothea Bergler, Swiss Red Cross; Patrick Amstutz,
Swiss Biotech Association / Molecular Partners; Dieter Gericke, Homburger;
Christoph Schmidt, up&up communication.
Founding Members include Ulf Grawunder, Founder and former CEO of NBE
Therapeutics; Bill Burns, former CEO of Roche Pharmaceuticals; Dominik Höchli,
former Head of Global Medical Affairs at Abbvie; Patrick Amstutz, CEO of
Molecular Partners and Chairman of Swiss Biotech Association, as well as
Molecular Partners, OM Pharma, the Swiss Biotech Association, HBM Healthcare
Investments and others.
About Life Science Cares Switzerland:
Life Science Cares Switzerland brings together the life science community and
local non-profit organizations to build bridges for people with limited
opportunities in our country. Our goal is to provide access to education and
opportunity for all who wish to develop beyond their own limitations - by
connecting the talents and minds of the life science community with the hearts
of non-profit organizations. Learn more at www.lifesciencecares.ch
(http://www.lifesciencecares.ch)
Contact:
Life Science Cares Switzerland
Nadine Zahnd-Straumann
Scheuchzerstrasse 35
CH-8006 Zürich
info@lifesciencecares.ch (mailto:info@lifesciencecares.ch)
www.lifesciencecares.ch (http://www.lifesciencecares.ch)
Â